Opioid

SAN FRANCISCO — Among prisoners, women were more likely to have opioid use disorder and more likely to receive treatment at intake compared with men, according to a poster presented here.

MIAMI BEACH, Fla. — Treatment with subcutaneous buprenorphine on a weekly or monthly basis eased cravings and withdrawals in those with opioid use disorder, per data from the American Society of Clinical Psychopharmacology annual meeting.

There has been a landscape of litigation to hold responsible parties accountable for their part in the opioid crisis.

The FDA announced that it has approved Brixadi, an extended-release subcutaneous injection for the treatment of moderate to severe opioid use disorder.

The FDA has approved Opvee as the first nalmefene hydrochloride prescription nasal spray to reverse opioid overdose in adults and children aged 12 years and older, according to a press release from the agency.

The prevalence of substance use among high school students was lower in 2021 compared with that in 2009 and 2019, although lifetime inhalant use was up from 2019, findings in the Morbidity and Mortality Weekly Report Supplement showed.

SAN DIEGO — “Now more than ever,” physicians need to manage opioid use disorder with pharmacological treatment in the primary care setting, according to a speaker at the ACP Internal Medicine Meeting.

From 2016 to 2022, initiation of buprenorphine for opioid use disorder increased, then plateaued prior to the COVID-19 pandemic, with a median monthly retention rate of about 20%, according to a research letter published in JAMA.

The FDA has granted de novo authorization for an opioid overdose-related prevention and alert system , according to a press release from the manufacturer.

Patients with chronic pain who received long-term opioid therapy had reductions in both pain and daily opioid doses following the use of an online pain management program, a recent study found.